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Fisetin, quercetin, luteolin and 7,8-hydroxyﬂavone show high activity in Leishmania cultures and present
low toxicity to mammalian cells. In this work, the structural aspects of 13 ﬂavonoids were analyzed for
their inhibition of the arginase enzyme from Leishmania (Leishmania) amazonensis. A higher potency of
arginase inhibition was observed with ﬁsetin, which was four and ten times greater than that of quercetin
and luteolin, respectively. These data show that the hydroxyl group at position 3 contributed signiﬁcantly
to the inhibitory activity of arginase, while the hydroxyl group at position 5 did not. The absence of the
catechol group on apigenin drastically decreased arginase inhibition. Additionally, the docking of com-
pounds showed that the inhibitors interact with amino acids involved in the Mnþ2 Mnþ2 metal bridge
formation at the catalytic site. Due to the low IC50 values of these ﬂavonoids, they may be used as a food
supplement in leishmaniasis treatment.
 2013 Elsevier Ltd. All rights reserved.1. Introduction
Leishmaniasis affects 12 million people in the world and is asso-
ciated with malnutrition, weakness of the immune system and
other factors related to a lack of resources. The disease primarily
affects people who live in poor housing conditions with limited ac-
cess to food (WHO, 2012). A balanced diet enriched with fruits and
vegetables can prevent cancer and cardiovascular diseases and
stimulates the immune system. In addition to their antioxidant
activities, bioactive food components, such as polyphenols, can
promote a healthy life (Hertog, Feskens, Hollman, Katan, & Kromh-
out, 1993). Several ﬂavonoids, such as luteolin, quercetin and
quercitrin, which are abundant dietary ﬂavones, are active against
some species of Leishmania (Mittra et al., 2000; Muzitano et al.,
2006; Sen, Mukhopadhyay, Ray, & Biswas, 2008; Tasdemir et al.,
2006).Quercetin and derived ﬂavonoids are active by oral
administration in experimental cutaneous and visceral leishmani-
asis infections produced in vivo (Gomes, Muzitano, Costa, &
Rossi-Bergmann, 2010; Muzitano et al., 2009).
We have recently shown that quercetin, quercitrin and isoqu-
ercitrin are potent inhibitors of Leishmania (Leishmania) amazonen-
sis arginase (ARG-L) (da Silva, Maquiaveli, & Magalhaes, 2012a).
Luteolin and quercetin promote k-DNA linearization mediated by
topoisomerase II, decrease DNA synthesis, arrest the cell cycle
and promote apoptosis of parasites (Mittra et al., 2000). Flavonoid
dimers have been developed as potent antileishmanial agents
(Wong, Chan, Chan, & Chow, 2012) and can reverse multidrug
resistance in Leishmania.
New therapeutic targets have been considered to treat
neglected diseases. For diseases caused by trypanosomatids, such
as Chagas disease, African sleeping sickness and leishmaniasis,
the exploration of the polyamine (PA) enzyme pathway has been
important in drug development (Colotti & Ilari, 2011). PAs are valu-
able targets for antiparasitic chemotherapy because they play an
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macromolecules and the antioxidant mechanism in Leishmania
(Birkholtz et al., 2011; Colotti & Ilari, 2011). The PA spermidine is
the substrate for the synthesis of trypanothione (N1, N8-bis (gluta-
tionil) spermidine) in Leishmania. Trypanothione promotes the re-
moval of reactive oxygen species (Fairlamb & Cerami, 1992) and
reactive nitrogen species (Bocedi et al., 2010), thus protecting the
parasite from oxidative stress and endogenous reactive species
produced by the host’s defence system.
The ARG-L hydrolyses L-arginine into L-ornithine and urea in the
ﬁrst step of PA biosynthesis. Double knockout of the ARG-L gene in
L. (L.) donovani showed that arginase plays a central role in poly-
amine synthesis (Roberts et al., 2004). In L. (L.) major, double
knockout of the ARG-L gene showed that the parasite becomes
auxotrophic for PAs (Reguera, Balaña-Fouce, Showalter, Hickerson,
& Beverley, 2009). ARG-L participates in a complex balance that
determines the fate of L-arginine, and its subcellular localization
in glycosomes may be essential for the physiological rhythm of
the parasite (da Silva, Zampieri, Muxel, Beverley, & Floeter-Winter,
2012b).
In mammals, there are two arginases: the hepatic arginase
(ARG-1) and the extra-hepatic arginase (ARG-2). ARG-1 can be in-
duced in macrophages under the TH2 lymphocyte response
(Wanderley & Barcinski, 2010). The increase of ARG-1 leads to
the consumption of L-arginine, which is also a substrate of nitric
oxide synthase. Nitric oxide synthase converts L-arginine to citrul-
line and nitric oxide (NO). As a consequence of increased ARG-1
activity, there is a decrease in the NO production that enables
Leishmania to survive inside the macrophage. The inhibition of
ARG-1 by endogenous NOHA (Nx-hydroxy-L-arginine) diminishes
the proliferation of Leishmania into the macrophage (Iniesta,
Gómez-Nieto, & Corraliza, 2001).
This study examines the biochemical interaction between
ARG-L and ﬂavonoids. Additionally, a docking simulation of the
interaction between inhibitors and the structural model of the
ARG-L allows visualization of the interactions of dietary ﬂavonoids
within the catalytic site of the enzyme.2. Materials and methods
2.1. Materials
Quercetin, isoquercitrin, quercitrin, luteolin, orientin, isoorien-
tin, ﬁsetin, galangin, kaempferol, 7,8-dihydroxyﬂavone, apigenin,
vitexin, isovitexin, MnSO4, L-arginine, CelLytic B, MOPS (4-mor-
pholinepropanesulfonic acid), CHES (2-(cyclohexylamino)ethane-
sulfonic acid), PMSF (phenyl-methyl-sulfonyl ﬂuoride), yeast
extract and tryptone were purchased from Sigma–Aldrich. Re-
agents for urea analysis were purchased from Quibasa (Belo Hori-
zonte, MG, Brazil).2.2. Expression and puriﬁcation of arginase
Recombinant ARG-L was expressed without a histidine tail and
puriﬁed as described previously (da Silva et al., 2012b). Rat liver
arginase (ARG-1) was prepared by lysing 5 g of liver cells in
100 ml of buffer containing 100 mM Tris and 1 mM EDTA, using
a blender. The homogenate was centrifuged at 5000g, and pig-
ments in the supernatant were removed by liquid chromatography
(open column) using 5 ml of Sepharose Chelating resin (GE Health-
care) charged with Niþ2. The resulting arginase solution was fully
activated by heat at 60 C in the presence of 10 mM of MnCl2
(Kanyo, Scolnick, Ash, & Christianson, 1996). Following activation,
the solution was centrifuged at 20,000g, and the supernatant was
used to test arginase inhibition.2.3. Inhibitor screening and determination of IC50
Screening of compounds for their ability to inhibit arginase
from L. (L.) amazonensis was performed using 125 lM concentra-
tions of each compound at pH 9.5 with 50 mM CHES buffer and
50 mM L-arginine (pH 9.5). The samples were incubated in a water
bath at 37 C for 15 min. Quantiﬁcation of urea was performed by
enzymatic colorimetric Berthelot assay (Fawcett & Scott, 1960),
using commercial reagents. Brieﬂy, the catalytic activity of the
arginase reactions was stopped by transferring 10 ll of reaction
mixture into 750 ll of reagent A (20 mM phosphate buffer, pH 7,
containing 60 mM salicylate, 1 mM sodium nitroprusside and
>500 IU of urease). This mixture was incubated at 37 C for
5 min. Next, 750 ll of reagent B (sodium hypochlorite 10 mM
and NaOH 150 mM) were added, and then the samples were incu-
bated at 37 C for 10 min (Fawcett et al., 1960). Absorbance mea-
surements were taken at 600 nm using a Hitachi 2810U
spectrophotometer. The positive and negative controls were per-
formed under the same conditions in the absence of inhibitor.
The experiments were performed in duplicate in at least three
independent experiments.
Determination of the concentration that inhibits 50% of the cat-
alytic activity of the enzyme was carried out by varying the inhib-
itor concentration with a 1:10 dilution factor. The experiments
were performed in duplicate in at least three independent experi-
ments until we obtained a coefﬁcient of non-linear regression
R2P 0.95. The different concentrations of the inhibitors were ob-
tained by serial dilution of the compound in water or a suitable sol-
vent. The reactions were performed at pH 9.5 using 50 mM CHES
buffer in the presence of 50 mM substrate L-arginine (pH 9.5).
The samples were incubated in a water bath at 37 C for 15 min,
and the urea formed was analyzed as described above. We used
a mathematical sigmoidal (log IC50) model to determine the IC50,
using Origin 8.0 software.
2.4. Determination of the constants Ki, K0i and mechanism of inhibition
All reactions were performed in 50 mM CHES buffer, pH 9.5,
containing variable concentrations of the substrate L-arginine
(12.5, 25, 50 and 100 mM) at pH 9.5. Inhibitors were used at three
different concentrations close to the IC50. The different substrate
and inhibitor concentrations were obtained by serial dilution. A
mixture, M1, containing L-arginine (pH 9.5) at double the desirable
concentration, and a second mixture, M2, containing the enzyme
(2000 units) diluted in 125 mM CHES buffer (pH 9.5), were pre-
pared. The reaction was prepared by mixing 50 ll of M1, 10 ll of
inhibitor and 40 ll of M2. The addition of M2 was synchronized
every 15 s, followed by immediate incubation in a water bath for
15 min at 37 C. The urea produced was analyzed as described
above. All reactions were performed in duplicate in a minimum
of three independent experiments.
The constant Ki was determined for inhibitors that showed
mechanisms of mixed or competitive inhibition, whereas K0i was
determined for inhibitors that showed uncompetitive or mixed
inhibition (Cornish-Bowden, 1974). Each constant was determined
by calculating x for the intersecting points between two lines ob-
tained by linear regression. For non-competitive inhibition, y = 0
was used for the equation to ﬁnd the values of the constants Ki
and K0i.
2.5. Data analysis
Statistical analysis was performed by ANOVA and post hoc
Tukey’s tests, using Origin 8.0. For all tests, differences of p < 0.05
were considered signiﬁcant. Linear regressions were obtained
using MS Excel 2010.
Table 1
Dissociation constants and the mode of arginase inhibition by natural compounds.
Ligand Structure 1IC50 Ki (lM) Ki’ Mode of inhibition
Isoquercitrina
OHO
O
O
OH
OH
OH
O
HO
OH
OH
OH
3,8* 6.9 ± 0.3 6.9 ± 0.3 Noncompetitive
Quercitrina
OHO
O
O
OH
OH
O
OH
OH
OH
OH 10* 7.2 ± 0.9 7.2 ± 0.9 Noncompetitive
DHFa
O
OH
HO
O
12 ± 1 7.4 ± 0.4 7.4 ± 0.4 Noncompetitive
Orientinb
OHO
O
OH
OH
O
OH
HO
HO
OH
OH
16 ± 2 – 24 ± 2 Uncompetitive
Isoorientinb
OHO
O
OH
OH
O
OH
HO
HO
OH
OH 9 ± 1 – 22 ± 2 Uncompetitive
Fisetinc
OHO
O
OH
OH
OH
1,4 ± 0,3 1.9 ± 0.5 4.2 ± 0.2 Mixed
Quercetind
OHO
O
OH
OH
OH
OH
4,3* 8 ± 1 12 ± 1 Mixed
Luteoline
OHO
O
OH
OH
OH
9 ± 1 8 ± 1 18 ± 2 Mixed
(continued on next page)
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Table 1 (continued)
Ligand Structure 1IC50 Ki (lM) Ki’ Mode of inhibition
Kaempferolf
OHO
O
OH
OH
OH
50 nd** nd nd
Galanging
OHO
O
OH
OH
100 nd nd nd
* da Silva, Maquiaveli, and Magalhaes, (2012a).
** nd = Not determined, DHF = 7,8-dihydroxyﬂavone.
1 Data are expressed as the median ± SEM. K0i differs for a compound without a common letter (p < 0.05).
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The target compounds (Table 1) were modeled in silico, and en-
ergy minimization was performed over 1000 steps, using the
steepest descent method, Gasteiger–Hückel charges, a dielectric
constant of 80, and the Tripos force ﬁeld. The structures were fur-
ther optimized by the conjugated gradient method.
The target enzyme used in this work was a previously con-
structed comparative model of ARG-L (da Silva, Castilho, Pioker,
Silva, & Floeter-Winter, 2002). The docking simulations (Dias &
de Azevedo, 2008) were carried out by applying the MolDock algo-
rithm (Thomsen & Christensen, 2006), which was implemented in
the Molegro Virtual Docker software (Molegro Virtual Docker/4.0
in, 2009).3. Results
3.1. Arginase inhibition by ﬂavonoids
A group of 13 ﬂavonoids (Table 1) was selected to determine a
structure–activity relationship using ARG-L as the drug target. The
compounds were screened at 125 lM concentrations in the pres-
ence of 50 mM substrate L-arginine at pH 9.5, the optimal pH of
the enzyme. Under these conditions, only three compounds, apige-
nin, isovitexin and vitexin, inhibited less than 50% of the enzyme
activity. Galangin and quercitrin achieved 50–70% inhibition,
whereas isoquercitrin, isoorientin and orientin achieved 70–75%
inhibition. The best inhibitors were ﬁsetin (87%), luteolin (83%),
quercetin (83%) and 7,8-dihydroxyﬂavone (80%). Using the same
conditions, these compounds did not signiﬁcantly inhibit ARG-1
from the rat, which was used as a model for the mammalian en-
zyme. At a concentration of 1 mM, all of the tested compounds
inhibited ARG-1 by <50%. Based on results from this study, the
ﬂavonoids showed speciﬁc inhibition of ARG-L, and did not act
through the ARG-1 route.
The interaction of ﬁsetin with ARG-1 was less stable than that
with ARG-L, conﬁrming the selectivity of ﬁsetin for the parasite en-
zyme. The energy value found for the interaction between ﬁsetin
and ARG-1 was 62.5 kcal/mol, compared to 85.8 kcal/mol with
the parasite ARG-L. Fisetin docking (Fig. 3) shows a rotation of
180 in the position of interactions with ARG-1 and ARG-L. There
is an inversion of ﬁsetin interaction with the distinct enzyme when
it looks for Ser150 and Asp245 in ARG-L, and equivalent amino
acids Ser137 and Asp234 in ARG-1: the catechol group from ﬁsetin
donates a hydrogen bond (H-bond) to Ser150 in ARG-L, while, in
ARG-1, the hydroxyl group at position 7 on the ﬂavone groupdonates an H-bond to Ser137, which is the position equivalent to
Ser150 in ARG-L. This inversion allows for a close hydrophobic
interaction of His154 and His139 with the double ring of the ﬂa-
vone group of ﬁsetin, and enhances the stability of this inhibitor
with ARG-L.
3.2. Mechanism of arginase inhibition by ﬂavonoids
The constants Ki and K0i refer to the equilibrium established be-
tween the enzyme (E) and substrate (S) in the presence of an inhib-
itor (I). The inhibition constant Ki refers to the dissociation
constant of the complex EI, while K0i refers to the dissociation of
the EIS (Cornish-Bowden, 1974). Eight compounds, with an IC50
of less than 20 lM, were selected for analysis of the mechanism
of enzyme inhibition.
The aglycone compounds, such as quercetin, luteolin and ﬁse-
tin, exhibited mixed inhibition, while the glycoside ﬂavonoids,
such as orientin and isoorientin, showed uncompetitive inhibition.
The compounds quercitrin, isoquercitrin and 7,8-dihydroxyﬂavone
showed non-competitive inhibition. Table 1 summarizes the ki-
netic data obtained with the Dixon and Cornish-Bowden plots that
were used to calculate the constants Ki and K0i (Fig. 1). The mixed
inhibition mechanism was set to the intersection point of the
straight curve that occurred in the second quadrant bounded by
the X and Y axes (counterclockwise) for the Dixon plot (Ki = x)
and the third quadrant for the Cornish-Bowden plot (K0i = x).
The mechanism of uncompetitive inhibition was determined at
the intersection of the Cornish–Bowden plot occurring in the sec-
ond quadrant and the intersection of the Dixon plot occurring at
y = 1(Ki>>>K0i).
3.3. Structure–activity relationship (SAR) of compounds
Fisetin (3,30,40,7-tetrahydroxyﬂavone) was four times more po-
tent than quercetin (3,30,40,5–7-pentahydroxyﬂavone), which indi-
cates that the hydroxyl at position 5 may not be necessary to
inhibit arginase. Moreover, quercetin, which has a hydroxyl at
position 3, is twice as potent as luteolin (3 0,4 0,5–7-
tetrahydroxyﬂavone).
Direct comparison of ﬁsetin with luteolin indicates that the hy-
droxyl at position 3 of ﬁsetin provides an inhibition ten times
greater than that when the hydroxyl is at position 5 in luteolin.
Surprisingly, tetrahydroxyﬂavone ﬁsetin was expected to have
the optimal number and a better distribution of hydroxyls, but
we found that 7,8-dihydroxyﬂavone (IC50 = 12 lM) presented an
IC50 close to the IC50 of luteolin (tetrahydroxyﬂavone).
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   A 
B 
C 
D 
isoquercitrin (µM)                  quercitrin (µM)                   orientin (µM)                  isoorientin (µM)
fisetin (µM) quercetin (µM)                        luteolin (µM)              7,8-dihydroxyflavone (µM)
fisetin (µM) quercetin (µM)                        luteolin (µM)              7,8-dihydroxyflavone (µM)
isoquercitrin (µM) quercitrin (µM)                orientin (µM)                   isoorientin (µM)
Fig. 1. The mechanism of arginase inhibition by eight ﬂavonoids. The Ki constants were measured using Dixon plots (A, C), and K0i constants were determined by a Cornish–
Bowden plot (B, D). Panel A and B: The aglicones ﬁsetin, quercetin and luteolin are mixed inhibitors (Ki– K0i), and 7,8-dihydroxyﬂavone is a noncompetitive inhibitor (Ki = K
0
i).
Panel C and D: quercitrin and isoquercitrin (glucosides derived from quercetin) are noncompetitive inhibitors, whereas orientin and isoorientin (glucosides derived from
luteolin) are uncompetitive inhibitors of ARG-L (Ki >>> K0i). The concentration of L-arginine used: 100 mM (d), 50 mM (), 25 mM (j) and 12.5 mM (N). The inhibitor
concentration was varied, ranging from 1.25 to 30 lM.
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Table 2
Energy docking results.
Ligand Edocking (kcal/mol) Ehb (kcal/mol) EvdW (kcal/mol) ESteric (kcal/mol) MW (u) Torsions
Isoquercetrin 144.40 24.00 44.31 173.96 464.38 4
Quercetrin 110.50 22.95 29.79 139.97 448.38 3
Orientin 98.21 19.02 7.49 139.71 448.38 3
Isoorientin 87.14 19.45 27.32 109.73 448.38 3
Fisetin 85.77 6.42 34.41 108.91 286.24 1
Quercetin 85.26 11.80 35.00 101.98 302.24 1
Luteolin 84.42 19.69 18.46 105.50 286.24 1
Kaempferol 81.62 11.79 31.86 98.79 286.24 1
7,8-Dihydroxyﬂavone 80.96 3.76 27.38 111.10 254.24 1
Galangin 77.20 5.42 31.98 101.53 270.24 1
Fig. 2. (A) Compounds docked in the ARG-L binding site. (B) A close-up image of the docked compounds in the ARG-L binding site. (C) Fisetin (gray) docking superposition
with L-arginine, in magenta (PDB: 1T5F). (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
2258 L.C. Manjolin et al. / Food Chemistry 141 (2013) 2253–2262A key feature of the inhibitors is the presence of the catechol
group because, in its absence, the compounds apigenin, vitexin
and isovitexin displayed no signiﬁcant inhibition. A comparative
analysis of quercetin and structurally related compunds (kaempf-
erol and galangin) showed that the catechol group is more impor-tant for inhibition than are the phenol and benzyl groups. The 7,8-
dihydroxyﬂavone, in which the aromatic ring has no hydroxyls,
contrasts with the other inhibitors. The hydroxyl at position 8
exhibited ten times the inhibition of galangin (benzyl group) and
ﬁve times the inhibition of kaempferol (phenol group).
Fig. 3. 2D-Representation of the compound-enzyme interactions. Black dashed and full green lines represent hydrogen and hydrophobic intermolecular interactions,
respectively. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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The optimum docking protocol was constructed with ﬂexibility
in the enzyme binding pocket (‘induced ﬁt’). Each compound wasdocked with softened potentials (steric, hydrogen bonding, and
electrostatic forces) and, at this point, the enzyme residues were
kept rigid at their default conformation. Then, all residue side-
chains that were close enough to the compound to interact with
Table 3
Cross-correlation matrix of the intermolecular energy terms.
Edocking Ehb EvdW ESteric MW Torsions
Edocking 1.00
Ehb 0.71 1.00
EvdW 0.31 0.16 1.00
ESteric 0.96 0.68 0.10 1.00
MW 0.74 0.84 0.10 0.78 1.00
Torsions 0.84 0.81 0.02 0.88 0.97 1.00
Fig. 3 (continued)
2260 L.C. Manjolin et al. / Food Chemistry 141 (2013) 2253–2262it were energy-minimized. The ﬁnal step was the energy minimiza-
tion of the compounds. The docking scores of the interactions be-
tween the arginase from L. amazonensis and the targetcompounds, as well as the hydrogen bonding, steric, and van der
Waals energy contributions and the number of possible atom–
atom free torsions, are shown in Table 2.
Fig. 2A shows the solvent-accessible surface of arginase from L.
amazonensis, including the docked compounds in the binding pock-
et. A close up of the docking interaction with the enzyme is shown
in Fig. 2B and C. Fig. 3 shows a 2D-representation of the ﬂavonoid-
enzyme interactions (Schomburg, Ehrlich, Stierand, & Rarey, 2010).
The intermolecular hydrogen bonds are shown as black dashed
lines in both Fig. 2B and Fig. 3. These hydrogen bonds serve as
‘‘molecular anchors’’ for binding the compounds into the enzyme
active site.
To semiquantitatively estimate the contribution of each energy
component to the docking score, a cross-correlation matrix of the
values shown in Table 2 was calculated (Table 3). The hydrogen
bonding and steric energy components, as well as the molecular
weights and numbers of free atom–atom bond torsions (entropic
contribution), are related to the docking score energies. Conse-
quently, those features should be considered carefully in the de-
sign of new lead compounds.
4. Discussion
Knowledge of the biology of the host-parasite relationship is
central to establishing a paradigm to treat leishmaniasis. PA syn-
thesis is a metabolic pathway that has been explored for drug
development against Trypanosoma and Leishmania (Colotti & Ilari,
2011). The inhibition of PA synthesis can cause oxidative stress
in parasite cells, due to a deﬁciency in trypanothione production
(Colotti & Ilari, 2011). Arginase from Leishmania is the ﬁrst enzyme
in the PA pathway, and blocking it can lead to oxidative stress and
promote infection control.
In a study of 105 natural compounds, the leishmanicidal activ-
ity of the ﬂavonoids ﬁsetin, quercetin, luteolin and 7,8-dihydroxyf-
lavone showed high potency against the amastigotes of L. (L.)
donovani (Tasdemir et al., 2006). These four compounds also
showed potential as inhibitors of ARG-L.
Fisetin is a ﬂavonoid present in strawberries; quercetin is abun-
dant in onions and broccoli, and luteolin can be found in celery,
green pepper, parsley and chamomile tea (Shimoi et al., 1998). In
this study, we observed that ﬁsetin is a ﬂavonoid that possesses
a high potency in arginase inhibition. Fisetin was the most potent
arginase inhibitor, with four and ten times higher potency than
quercetin and luteolin, respectively. Comparing the structures of
these ﬂavonoids revealed that the hydroxyl group at position 3
contributed signiﬁcantly to the inhibitory activity of arginase,
while the hydroxyl at position 5 did not.
In the absence of a catechol group on the galangin, arginase
inhibition declined sharply, suggesting that the catechol group is
important for inhibition activity. The absence of a hydroxyl group
at position 3 and catechol on the apigenin inhibited only 6% of
ARG-L at 125 lM. C-glycosylation on the isoorientin (luteolin-6-
C-glucoside) and the orientin (luteolin-8-C-glucoside) did not en-
hance arginase inhibition. In contrast, the 7,8-dihydroxyﬂavone
showed an IC50 of 12 lM when the hydroxyl at position 3 and
L.C. Manjolin et al. / Food Chemistry 141 (2013) 2253–2262 2261the catechol group were absent. These data indicate that position 8
enhanced the inhibition activity of this compound.
The inhibition of ARG-L increased due to the hydroxylation of
the phenyl group of molecules hydroxylated at positions 3, 5,
and 7, such as in galangin (IC50 100 lM), kaempferol (IC50
50 lM) and quercetin (IC50 4.3 lM). Galangin is not hydroxylated,
kaempferol is hydroxylated at position 40 (phenol group), and
quercetin is hydroxylated at positions 30 and 40, generating a cate-
chol group. The inhibition activity of quercetin is not signiﬁcantly
altered if the hydroxyl at position 3 is conjugated with glucose to
generate isoquercitrin, but it loses half of its potency if this posi-
tion is conjugated with rhamnose, as in quercitrin (da Silva et al.,
2012a).
Structural analysis from docking studies (Fig. 3) showed hydro-
gen bond (H-bond) interaction between ARG-L and the substituent
at the 3-positions present in isoquercitrin (quercetin-3-O-b-gluco-
side) and quercitrin (quercetin-3-O-rhamnoside) that inhibit ARG-
L by a noncompetitive mechanism, where an inhibitor binds to
both the enzyme-substrate complex or to the free enzyme. The
higher docking energies were observed just for these 2 compounds
(Table 2). In C-glucosides, such as orientin (luteolin-8-C-glucoside)
and isoorientin (luteolin-6-C-glucoside), the glucoside group does
not show any interaction with ARG-L residues, and both are
uncompetitive inhibitors which bind exclusively to the enzyme–
substrate complex, resulting in an inactivated enzyme–sub-
strate–inhibitor complex. The aglycones ﬁsetin and luteolin show
common H-bonds with residues Asp245 and Ser150, and quercetin
is a unique compound that shows H-bonding with His28 and
Glu197. These three aglycones showed mixed inhibition of ARG-
L. In conclusion, the three mechanisms of inhibition shown here
for these compounds were closely related to the absence or pres-
ence of a glucoside in the 3-O-glucoside position, where mixed
and noncompetitive inhibition are observed, respectively, while
the C-glucoside showed an uncompetitive inhibition.
There are now multiple targets that have been described for the
leishmanicidal action of ﬂavonoids. Quercetin inhibits ARG-L and
ribonucleotide reductase (da Silva et al., 2012a; Sen et al., 2008).
Quercetin induces cell death by increasing ROS (reactive oxygen
species) and causing mitochondrial dysfunction in L. (L.) amazonen-
sis (Fonseca-Silva, Inacio, Canto-Cavalheiro, & Almeida-Amaral,
2011). Luteolin and quercetin promote apoptosis mediated by
topoisomerase II, resulting in kinetoplast DNA cleavage in L. (L.)
donovani (Mittra et al., 2000).
The Edocking (Table 2) results support the IC50 (Table 1) data ob-
tained from the aglycones and glycoside ﬂavonoids. The only
exception was that 7,8-dihydroxyﬂavone had an IC50 lower than
those of kaempferol and galangin. Docking suggested interactions
between the ﬂavonoids and the amino acids Asp137, Asp141,
Asp243, Asp245 and His139 (ARG-L numbering) that are involved
in metal bridge Mn2þA Mn2þB coordination in the active site of argi-
nase (Kanyo et al., 1996). Another important interaction can be
attributed to His154, which is a conserved amino acid involved
in substrate binding (Ash, 2004). His 139 and His 154 showed
hydrophobic intermolecular interactions with several ﬂavonoids
(Fig. 3).
Leishmaniasis is a complex disease; therefore, the use of spe-
ciﬁc targets in rational drug design is not the ideal approach to
treat this illness (Cavalli & Bolognesi, 2009). The multiple targets
of action of quercetin, luteolin and ﬁsetin, make these compounds
candidates for drug design against leishmaniasis. Future research
could determine whether ﬁsetin, luteolin and quercetin can be
used as a lead or prototype drug with multiple targets for the treat-
ment of leishmaniasis.
In conclusion, the in vitro and in silico study of these compounds
can facilitate rational drug design and the development of new,
safer drugs to treat leishmaniasis, using arginase as a drug target.Moreover, the low IC50 values observed here may lead to the use
of ﬂavonoids as dietary supplements for leishmaniasis patients.Acknowledgments
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